| PERIOD ENDING | 31-Oct-08 | 31-Oct-07 | | Total Revenue | 168,160 | 73,115 | | Cost of Revenue | 14,787 | 10,319 | | | Gross Profit | 153,373 | 62,796 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 2,075 | 1,442 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 151,298 | 61,354 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,371,355) | (102,582) | | Earnings Before Interest And Taxes | 151,298 | 61,354 | | Interest Expense | 1,985 | 10 | | Income Before Tax | 149,313 | 61,343 | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (1,222,042) | (41,239) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (1,222,042) | (41,239) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($1,222,042) | ($41,239) |
|
0.83% Nasdaq 0.00%
Income Statement
